Publications by authors named "Joshua Veatch"

Claim this Profile
S
Survival Correlates With Adjuvant Choice in Sentinel Node Positive Head and Neck Cutaneous Melanoma.
Sina Dadafarin, Mohammed A Alvi, Sean T Massa, Joshua Veatch, Zain H Rizvi

Laryngoscope· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mixed-method analysis of oncologist-patient communications about immune checkpoint inhibitors (COACH).
Wenwen Chen, Julia Majovski, Shailender Bhatia, Anissa Chan, Petros Grivas, Joshua R Veatch

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent treatment with transarterial immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanoma.
Natalie J Miller, Sharon W Kwan, Jacob B Leary, Daniel S Hippe, William McCamy, Joshua R Veatch

Cancer Immunol Immunother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma.
Yuta Asano, Joshua Veatch, Megan McAfee, Jakob Bakhtiari, Bo Lee

medRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.
Erica T Goddard, Miles H Linde, Shivani Srivastava, Grant Klug, Tamer B Shabaneh, Joshua R Veatch

Cancer Cell· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Joshua Veatch

Cancer Immunol Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Joshua Veatch

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem-cell-like CD4 T cells prey on MHC class II-negative tumors.
Joshua R Veatch, Stanley R Riddell

Nat Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer.
Joshua R Veatch, Stanley R Riddell

Cell· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study.
Arthur Sillah, Ulrike Peters, Nathaniel F Watson, Scott S Tykodi, Evan T Hall, Joshua Veatch

Support Care Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen-specific CD4 T cells in human melanoma have diverse differentiation states and correlate with CD8 T cell, macrophage, and B cell function.
Joshua R Veatch, Sylvia M Lee, Carolyn Shasha, Naina Singhi, Julia L Szeto

Cancer Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer.
Joshua R Veatch, Sylvain Simon, Stanley R Riddell

Nat Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells.
Joshua R Veatch, Naina Singhi, Shivani Srivastava, Julia L Szeto, Brenda Jesernig

J Clin Invest· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentary.
Arthur Sillah, Scott S Tykodi, Evan T Hall, John A Thompson, Nathaniel F Watson, Joshua Veatch

Future Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab.
Joshua R Veatch, Naina Singhi, Brenda Jesernig, Kelly G Paulson, Jonathan Zalevsky

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Specific Incidence of Melanoma in the United States.
Kelly G Paulson, Deepti Gupta, Teresa S Kim, Joshua R Veatch, David R Byrd

JAMA Dermatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous CD4 T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic and () Driver Mutations.
Joshua R Veatch, Brenda L Jesernig, Julia Kargl, Matthew Fitzgibbon, Sylvia M Lee

Cancer Immunol Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.
Joshua R Veatch, Sylvia M Lee, Matthew Fitzgibbon, I-Ting Chow, Brenda Jesernig

J Clin Invest· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia.
Joshua R Veatch, Vicky Sandhu, Pamela S Becker, John M Pagel, Frederick R Appelbaum

Blood· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect.
Joshua R Veatch, Michael A McMurray, Zara W Nelson, Daniel E Gottschling

Cell· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends.
Anne E Stellwagen, Zara W Haimberger, Joshua R Veatch, Daniel E Gottschling

Genes Dev· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis